Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis

Laboratory Investigation

Volumn 84, Issue 8, 2004, Pages 999-1012

  Blanco, David ^a   Vicent, Silvestre ^a   Elizegi, Eider ^a   Pino, Irene ^a   Fraga, Mario F ^c   Esteller, Manel ^c   Saffiotti, Umberto ^b   Lecanda, Fernando ^a   Montuenga, Luis M ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Adhesion molecules; Cadherin; Catenin; DNA methylation; EMT; Lung cancer; Tight junction

Indexed keywords

ALPHA CATENIN; BETA CATENIN; CELL ADHESION MOLECULE; NERVE CELL ADHESION MOLECULE; SILICON DIOXIDE; UVOMORULIN; VIMENTIN;

ADENOMATOID TUMOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CANCER GROWTH; CELL ADHESION; CELL HYPERPLASIA; CELL JUNCTION; CONTROLLED STUDY; CYTOPLASM; DNA METHYLATION; EVIDENCE BASED MEDICINE; FEMALE; INFLAMMATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS CELL TYPE 2; LUNG ALVEOLUS EPITHELIUM; LUNG CARCINOGENESIS; LUNG PARENCHYMA; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SQUAMOUS CELL CARCINOMA;

ALPHA CATENIN; ANIMALS; BASE SEQUENCE; BETA CATENIN; CADHERINS; CELL ADHESION; CELL ADHESION MOLECULES; CYTOSKELETAL PROTEINS; DNA; DNA METHYLATION; EPITHELIUM; FEMALE; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MEMBRANE PROTEINS; MESODERM; PHOSPHOPROTEINS; RATS; RATS, INBRED F344; SILICON DIOXIDE; TRANS-ACTIVATORS;

EID: 3543052213     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: 10.1038/labinvest.3700129     Document Type: Article

References (77)

1. Knust E, Bossinger O. Composition and formation of intercellular junctions in epithelial cells. Science 2002;298:1955-1959.
2. Tsukita S, Furuse M, Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001;2:285-293.
3. Jamora C, Fuchs E. Intercellular adhesion, signalling and the cytoskeleton. Nat Cell Biol 2002;4:101-108.
4. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer 2002;36:115-124.
5. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-991.
6. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
7. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002;21:5427-5440.
8. Islam S, Carey TE, Wolf GT, et al. Expression of N-cadherin by human squamous carcinoma cells induces a scattered fibroblastic phenotype with disrupted cell-cell adhesion. J Cell Biol 1996;135:1643-1654.
9. Tomita K, van Bokhoven A, van Leenders GJ, et al. Cadherin switching in human prostate cancer progression. Cancer Res 2000;60:3650-3654.
10. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
11. Arias AM. Epithelial-mesenchymal interactions in cancer and development. Cell 2001;105:425-431.
12. Cheng SL, Lecanda F, Davidson MK, et al. Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res 1998;13:633-644.
13. Prasad S, Soldatenkov VA, Srinivasarao G, et al. Intermediate filament proteins during carcinogenesis and apoptosis (Review). Int J Oncol 1999;14:563-570.
14. Nagle RB. Intermediate filament expression in prostate cancer. Cancer Metast Rev 1996;15:473-482.
15. Ruoslahti E. Fibronectin and its integrin receptors in cancer. Adv Cancer Res 1999;76:1-20.
16. Stewart M. Intermediate filament structure and assembly. Curr Opin Cell Biol 1993;5:3-11.
17. Gilles C, Polette M, Piette J, et al. Vimentin expression in cervical carcinomas: association with invasive and migratory potential. J Pathol 1996;180:175-180.
18. Hendrix MJ, Seftor EA, Seftor RE, et al. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior. Am J Pathol 1997;150:483-495.
19. Mao L. Molecular abnormalities in lung carcinogenesis and their potential clinical implications. Lung Cancer 2001;34(Suppl 2):S27-S34.
20. Saffiotti U, Williams A, Daniel L, et al. Carcinogenesis by crystalline silica: animal, cellular and molecular sudies. In: Castranova V, Vallyathan V, Wallace W (eds). Silica and Silica-induced Lung Diseases. CRC Press: Boca Raton, FL, 1996, pp 345-381.
21. Williams AO, Flanders KC, Saffiotti U. Immunohistochemical localization of transforming growth factor-beta 1 in rats with experimental silicosis, alveolar type II hyperplasia, and lung cancer. Am J Pathol 1993;142:1831-1840.
22. Saffiotti U, Daniel LN, Mao Y, et al. Biological studies on the carcinogenic mechanisms of quartz. Rev Mineral 1993;28:523-544.
23. Warheit DB. Inhaled amorphous silica particulates: what do we know about their toxicological profiles? J Environ Pathol Toxicol Oncol 2001;20(Suppl 1): 133-141.
24. Brabletz T, Herrmann K, Jung A, et al. Expression of nuclear beta-catenin and c-myc is correlated with tumor size but not with proliferative activity of colorectal adenomas. Am J Pathol 2000;156:865-870.
25. Fraga MF, Uriol E, Borja Diego L, et al. High-performance capillary electrophoretic method for the quantification of 5-methyl 2′-deoxycytidine in genomic DNA: application to plant, animal and human cancer tissues. Electrophoresis 2002;23:1677-1681.
26. Esteller M, Fraga MF, Guo M, et al. DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001;10:3001-3007.
27. Herman JG, Graff JR, Myohanen S, et al. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996;93:9821-9826.
28. Esteller M, Sparks A, Toyota M, et al. Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer. Cancer Res 2000;60:4366-4371.
29. Emmendoerffer A, Hecht M, Boeker T, et al. Role of inflammation in chemical-induced lung cancer. Toxicol Lett 2000;112-113:185-191.
30. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology (Huntingt) 2002;16:217-226. 229; discussion 230-232.
31. Ballaz S, Mulshine JL. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003;5:46-62.
32. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001;1:46-54.
33. Pirinen RT, Hirvikoski P, Johansson RT, et al. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 2001;54:391-395.
34. Kase S, Sugio K, Yamazaki K, et al. Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res 2000;6:4789-4796.
35. Kimura K, Endo Y, Yonemura Y, et al. Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer. Int J Oncol 2000;16:1125-1131.
36. Hao XP, Pretlow TG, Rao JS, et al. Beta-catenin expression is altered in human colonic aberrant crypt foci. Cancer Res 2001;61:8085-8088.
37. Suzuki T, Yano H, Nakashima Y, et al. Beta-catenin expression in hepatocellular carcinoma: a possible participation of beta-catenin in the dedifferentiation process. J Gastroenterol Hepatol 2002;17:994-1000.
38. Huiping C, Kristjansdottir S, Jonasson JG, et al. Alterations of E-cadherin and beta-catenin in gastric cancer. Bmc Cancer 2001;1:16.
39. Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001;61:8401-8404.
40. Haydon RC, Deyrup A, Ishikawa A, et al. Cytoplasmic and/or nuclear accumulation of the beta-catenin protein is a frequent event in human osteosarcoma. Int J Cancer 2002;102:338-342.
41. Ishigaki K, Namba H, Nakashima M, et al. Aberrant localization of beta-catenin correlates with overexpression of its target gene in human papillary thyroid cancer. J Clin Endocrinol Metab 2002;87:3433-3440.
42. Shibanuma H, Hirano T, Tsuji K, et al. Influence of E-cadherin dysfunction upon local invasion and metastasis in non-small cell lung cancer. Lung Cancer 1998;22:85-95.
43. Rodriguez-Salas N, Palacios J, de Castro J, et al. Beta-catenin expression pattern in small cell lung cancer: correlation with clinical and evolutive features. Histol Histopathol 2001;16:353-358.
44. Retera JM, Leers MP, Sulzer MA, et al. The expression of beta-catenin in non-small-cell lung cancer: a clinicopathological study. J Clin Pathol 1998;51:891-894.
45. Nawrocki B, Polette M, Van Hengel J, et al. Cytoplasmic redistribution of E-cadherin-catenin adhesion complex is associated with down-regulated tyrosine phosphorylation of E-cadherin in human bronchopulmonary carcinomas. Am J Pathol 1998;153:1521-1530.
46. Clavel CE, Nollet F, Berx G, et al. Expression of the E-cadherin-catenin complex in lung neuroendocrine tumours. J Pathol 2001;194:20-26.
47. Hommura F, Furuuchi K, Yamazaki K, et al. Increased expression of beta-catenin predicts better prognosis in nonsmall cell lung carcinomas. Cancer 2002;94:752-758.
48. Kotsinas A, Evangelou K, Zacharatos P, et al. Proliferation, but not apoptosis, is associated with distinct beta-catenin expression patterns in non-small-cell lung carcinomas: relationship with adenomatous polyposis coli and G(1)-to S-phase cell-cycle regulators. Am J Pathol 2002;161:1619-1634.
49. Hajra KM, Fearon ER. Cadherin and catenin alterations in human cancer. Genes Chromosomes Cancer 2002;34:255-268.
50. Kallakury BV, Sheehan CE, Winn-Deen E, et al. Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas. Cancer 2001;92:2786-2795.
51. Yoshiura K, Kanai Y, Ochiai A, et al. Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas. Proc Natl Acad Sci USA 1995;92:7416-7419.
52. Rodrigo I, Cato AC, Cano A. Regulation of E-cadherin gene expression during tumor progression: the role of a new Ets-binding site and the E-pal element. Exp Cell Res 1999;248:358-371.
53. Bolos V, Peinado H, Perez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: a comparison with Snail and E47 repressors. J Cell Sci 2003;116:499-511.
54. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
55. Guaita S, Puig I, Franci C, et al. Snail induction of epithelial to mesenchymal transition in tumor cells is accompanied by MUC1 repression and ZEB1 expression. J Biol Chem 2002;277:39209-39216.
56. Reichert M, Muller T, Hunziker W. The PDZ domains of zonula occludens-1 induce an epithelial to mesenchymal transition of Madin-Darby canine kidney I cells. Evidence for a role of beta-catenin/Tcf/Lef signaling. J Biol Chem 2000;275:9492-9500.
57. Balda MS, Garrett MD, Matter K. The ZO-1-associated Y-box factor ZONAB regulates epithelial cell proliferation and cell density, J Cell Biol 2003;160:423-432.
58. Hoover KB, Liao SY, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998;153:1767-1773.
59. Ando-Akatsuka Y, Yonemura S, Itoh M, et al. Differential behavior of E-cadherin and occludin in their co-localization with ZO-1 during the establishment of epithelial cell polarity. J Cell Physiol 1999;179:115-125.
60. Itoh M, Nagafuchi A, Moroi S, et al. Involvement of ZO-1 in cadherin-based cell adhesion through its direct binding to alpha catenin and actin filaments. J Cell Biol 1997;138:181-192.
61. Balda MS, Matter K. Tight junctions. J Cell Sci 1998;111:541-547.
62. Kim JB, Islam S, Kim YJ, et al. N-cadherin extracellular repeat 4 mediates epithelial to mesenchymal transition and increased motility. J Cell Biol 2000;151:1193-1206.
63. Nieman MT, Prudoff RS, Johnson KR, et al. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-644.
64. Hazan RB, Kang L, Whooley BP, et al. N-cadherin promotes adhesion between invasive breast cancer cells and the stroma. Cell Adhes Commun 1997;4:399-411.
65. Nakatsuji S, Yamate J, Sakuma S. Relationship between vimentin expressing renal tubules and interstitial fibrosis in chronic progressive nephropathy in aged rats. Virchows Arch 1998;433:359-367.
66. Okada H, Ban S, Nagao S, et al. Progressive renal fibrosis in murine polycystic kidney disease: an immunohistochemical observation. Kidney Int 2000;58:587-597.
67. Boyer B, Valles AM, Edme N. Induction and regulation of epithelial-mesenchymal transitions. Biochem Pharmacol 2000;60:1091-1099.
68. Savagner P. Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays 2001;23:912-923.
69. Bhowmick NA, Ghiassi M, Bakin A, et al. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol Biol Cell 2001;12:27-36.
70. Grande M, Franzen A, Karlsson JO, et al. Transforming growth factor-beta and epidermal growth factor synergistically stimulate epithelial to mesenchymal transition (EMT) through a MEK-dependent mechanism in primary cultured pig thyrocytes. J Cell Sci 2002;115:4227-4236.
71. Cui W, Fowlis DJ, Bryson S, et al. TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 1996;86:531-542.
72. Yi JY, Hur KC, Lee E, et al. TGFbeta1-mediated epithelial to mesenchymal transition is accompanied by invasion in the SiHa cell line. Eur J Cell Biol 2002;81:457-468.
73. DeLuca SM, Gerhart J, Cochran E, et al. Hepatocyte growth factor/scatter factor promotes a switch from E- to N-cadherin in chick embryo epiblast cells. Exp Cell Res 1999;251:3-15.
74. Elizegi E, Pino I, Vicent S, et al. Hyperplasia of alveolar neuroendocrine cells in rat lung carcinogenesis by silica with selective expression of proadrenomedullin-derived peptides and amidating enzymes. Lab Invest 2001;81:1627-1638.
75. Saffiotti U. The pathology induced by silica in relation to fibrogenesis and carcinogenesis. In: Goldsmith DF, Winn DM, Shy CM (eds). Silica, Silicosis and Cancer. Praeger: New York, 1986, pp 287-307.
76. Williams AO, Saffiotti U. Transforming growth factor beta1, ras and p53 in silica-induced fibrogenesis and carcinogenesis. Scand J Work Environ Health 1995;21(Suppl 2):30-34.
77. Williams AO, Knapton AD, Ifon ET, et al. Transforming growth factor beta expression and transformation of rat lung epithelial cells by crystalline silica (quartz). Int J Cancer 1996;65:639-649.